Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
about
Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung diseaseNew use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis.Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial.
P2860
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
@ast
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
@en
type
label
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
@ast
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
@en
prefLabel
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
@ast
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
@en
P2093
P2860
P1476
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
@en
P2093
David P Nichols
Jennifer L Taylor-Cousar
Kelsey A Von Kessel
Robert Young
P2860
P407
P577
2010-08-10T00:00:00Z